BamSEC and AlphaSense Join Forces
Learn More

Warner Chilcott Plc

Formerly NASDAQ: WCRX

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from 425 13 pages Dated May 19, 2013 Warner Chilcott Plc and Actavis, Inc. Expenses Reimbursement Agreement Contents
12/34/56
EX-2.3
from 8-K 13 pages Dated May 19, 2013 Warner Chilcott Plc and Actavis, Inc. Expenses Reimbursement Agreement Contents
12/34/56
EX-2.2
from 425 13 pages Appendix III Conditions of the Acquisition and the Scheme Part A
12/34/56
EX-2.2
from 8-K 13 pages Appendix III Conditions of the Acquisition and the Scheme Part A
12/34/56
EX-2.1
from 425 113 pages Dated May 19, 2013 Warner Chilcott Plc, Actavis, Inc., Actavis Limited, Actavis Ireland Holding Limited, Actavis W.C. Holding LLC, and Actavis W.C. Holding 2 LLC Transaction Agreement Dublin Contents
12/34/56
EX-2.1
from 8-K 113 pages Dated May 19, 2013 Warner Chilcott Plc, Actavis, Inc., Actavis Limited, Actavis Ireland Holding Limited, Actavis W.C. Holding LLC, and Actavis W.C. Holding 2 LLC Transaction Agreement Dublin Contents
12/34/56
EX-2.1
from 8-K 51 pages Asset Purchase Agreement by and Among Novartis Pharmaceuticals Corporation and Novartis Pharma AG and Warner Chilcott Company, LLC and Warner Chilcott Plc
12/34/56
EX-2
from SC 13G/A ~5 pages Joint Filing Agreement
12/34/56
EX-2.3
from 10-K 33 pages Transition Services Agreement by and Between the Procter & Gamble Company and Company Effective as of October 30, 2009
12/34/56
EX-2.1
from 8-K 43 pages Asset Purchase Agreement Dated as of September 23, 2009 Among Leo Pharma a/S, Leo Laboratories Ltd., Warner Chilcott Plc, Warner Chilcott Company, LLC and Warner Chilcott (US), LLC
12/34/56
EX-2.1
from 8-K 103 pages Purchase Agreement Between the Procter & Gamble Company and Warner Chilcott Plc Dated as of August 24, 2009
12/34/56
EX-2
from SC 13G ~5 pages Joint Filing Agreement
12/34/56